Genetics of age-related macular degeneration

Michael Klein, Peter J. Francis

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Gene discoveries will lead to more effective therapies for AIMED by identifying specific underlying disease mechanisms that might be corrected by drugs or gene therapy. For example, investigations are currently being carried out using pigment epithelium-derived factor (PEDE). The gene for this potent inhibitor of angiogenesis has been incorporated into an adenoviral vector and delivered into the eye by intravitreal injection [95] to inhibit growth of new blood vessels in eyes with neovascular AMD. In the future, as the genetics of this complex disease are unraveled, more effective treatments and preventative measures that target specific molecular defects underlying the development of AMD can be expected.

Original languageEnglish (US)
Pages (from-to)567-574
Number of pages8
JournalOphthalmology Clinics of North America
Volume16
Issue number4
DOIs
Publication statusPublished - Dec 2003

    Fingerprint

ASJC Scopus subject areas

  • Ophthalmology

Cite this